Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for prevention of amphotericin-induced nephrotoxicity and electrolyte imbalances
IRCT2016071328901N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in mycoses, sponsored by Isfahan University of Medical Sciences. Primary endpoints: Prevention of amphotericin-induced nephrotoxicity and Prevention of amphotericin-induced electrolyte imbalances. Started Sep 2016; status: completed.
02
Drugs
pentoxifylline
03
Conditions
mycoses
Beyond the preview
Go deeper on IRCT2016071328901N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016071328901N1.